Efficacy and tolerability of Menorest® 50 compared with estraderm® TTS 50 in the treatment of postmenopausal symptoms. A randomized, multicenter, parallel group study
- 30 November 1995
- Vol. 22 (3) , 207-218
- https://doi.org/10.1016/0378-5122(95)00938-h
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Bioavailability Study of Menorest®, a New Estrogen Transdermal Delivery System, Compared with a Transdermal Reservoir SystemClinical Drug Investigation, 1995
- A Risk-Benefit Appraisal of Transdermal Estradiol TherapyDrug Safety, 1993
- Preventive effects of transdermal 17β-estradiol on osteoporotic changes after surgical menopause: A two-year placebo-controlled trialAmerican Journal of Obstetrics and Gynecology, 1993
- Comparison of transdermal and oral estrogen-progestin replacement therapy: Effects on serum lipids and lipoproteinsAmerican Journal of Obstetrics and Gynecology, 1992
- Neuroendocrine and clinical effects of transdermal 17β-estradiol in postmenopausal womenMaturitas, 1991
- Transdermal oestrogen replacement therapy in a Finnish populationMaturitas, 1991
- Transdermal EstradiolDrugs, 1990
- Hip Fracture and the Use of Estrogens in Postmenopausal WomenNew England Journal of Medicine, 1987
- Long-Term Estrogen Replacement Therapy Prevents Bone Loss and FracturesAnnals of Internal Medicine, 1985
- Estrogen use and all-cause mortality. Preliminary results from the Lipid Research Clinics Program Follow-Up StudyJAMA, 1983